Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets

Immunity(2021)10.1016/j.immuni.2021.05.001Source: DataRank Database

Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets is a research paper published in Immunity (2021). On theSindex it has a DataRank of 0. It has been cited 148 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access148 citations

Download PDF

Cite:

Linked data & code

geo gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (25 grants)Impact (FWCI 7.49)OA: bronzeTopics (85)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (32)

Christopher T. Stamper ORCID,Lei Li ORCID,Siriruk Changrob ORCID,Nicholas Asby ORCID,Peter Halfmann ORCID

Live enrichment

PubMed:34022127 PMC:PMC8101792 OpenAlex:https://openalex.org/W3157116442

National Institutes of Health

Grant: F30 AI152327

National Institutes of Health

Grant: T32 CA009594

National Institutes of Health

Grant: R01 AI157155

National Institutes of Health

Grant: U19AI057266

National Institutes of Health

Grant: U19AI082724

National Institutes of Health

Grant: U19AI109946

Japan Agency for Medical Research and Development

Grant: JP19fk0108113

Japan Agency for Medical Research and Development

Grant: JP20fk0108272

Open Philanthropy Project

Grant: 2020-215611

U.S. Department of Health and Human Services

Grant: HHSN272201700060C

U.S. Department of Health and Human Services

Grant: HHSN272201400008C

University of Chicago

Grant: SCR_019196

University of Chicago

Grant: SCR_017760

National Institute of Allergy and Infectious Diseases

Grant: 75N93019C00062

National Institute of Allergy and Infectious Diseases

Grant: 75N93019C00051

NIAID NIH HHS

Grant: HHSN272201400005C

NIAID NIH HHS

Grant: T32 AI007090

National Institutes of Health

Grant: 5R01AI157155-02

Human antibody-based countermeasures against the Coronavirus SARS-CoV-2

National Institutes of Health

Grant: 3U19AI057266-05S1

IMMUNOLOGICAL MEMORY TO VACCINATION

National Institutes of Health

Grant: 5U19AI082724-10

University of Chicago Autoimmunity Center of Excellence

National Institutes of Health

Grant: 5T32CA009594-09

GRADUATE TRAINING PROGRAM IN CANCER BIOLOGY

National Institutes of Health

Grant: 5U19AI109946-05

Mechanisms of broadly neutralizing humoral immunity against influenza viruses

National Institutes of Health

Grant: 1F30AI152327-01A1

Regulation of Antiviral Responses in Plasmacytoid Dendritic Cells to Chikungunya Virus by the Gut Microbiota

Icahn School of Medicine at Mount Sinai

JPB Foundation

FWCI

7.49

Citation Percentile

1.0%

Citation Trend

2013

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S1074761321001989/pdf

publisherhttp://www.cell.com/article/S1074761321001989/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1074761321001989?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1074761321001989?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.immuni.2021.05.001

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesT-cell and B-cell Immunology0301 basic medicine03 medical and health sciences0302 clinical medicineAntibodies, NeutralizingAntibodies, ViralAntibody FormationB-LymphocytesCOVID-19Computational BiologyCross ReactionsEpitope MappingFemaleGene Expression ProfilingHigh-Throughput Nucleotide SequencingHost-Pathogen InteractionsHumansImmunodominant EpitopesImmunologic MemoryMaleNeutralization TestsSARS-CoV-2Single-Cell AnalysisSpike Glycoprotein, CoronavirusTranscriptome

MeSH Terms

COVID-19SARS-CoV-2Antibodies, ViralAntibody FormationB-LymphocytesCross ReactionsFemaleHumansImmunologic MemoryMaleNeutralization TestsImmunodominant EpitopesEpitope MappingComputational BiologyGene Expression ProfilingHost-Pathogen InteractionsAntibodies, NeutralizingSingle-Cell AnalysisHigh-Throughput Nucleotide SequencingTranscriptomeSpike Glycoprotein, Coronavirus

Keywords

BiologyImmunodominanceVirologyAntibodyAntigenMemory B cellNeutralizing antibodyMonoclonal antibodyImmunologyB cellEpitopespikenucleoproteinRna SequencingPreexisting ImmunityOrf8Covid-19Sars-cov-2MaleB-LymphocytesImmunodominant EpitopesGene Expression ProfilingComputational BiologyHigh-Throughput Nucleotide SequencingCross ReactionsAntibodies, ViralAntibodies, NeutralizingArticleNeutralization TestsAntibody FormationHost-Pathogen InteractionsSpike Glycoprotein, CoronavirusHumansFemaleSingle-Cell AnalysisImmunologic MemoryEpitope Mapping

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets

FAIR Checklist

Authors (32)

Funding (25 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)